Cargando…

Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research

Cardiovascular Diseases (CVD) have a high disease burden in India. Dyslipidemia, a major CVD risk factor, requires effective management. Our review describes the appropriateness of the international dyslipidemia guidelines in the Indian context. A systematic search was performed in PubMed, Google Sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Misra, Sanjana, Lyngdoh, Tanica, Mulchandani, Rubina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647649/
https://www.ncbi.nlm.nih.gov/pubmed/35940234
http://dx.doi.org/10.1016/j.ihj.2022.07.009
_version_ 1784827420549840896
author Misra, Sanjana
Lyngdoh, Tanica
Mulchandani, Rubina
author_facet Misra, Sanjana
Lyngdoh, Tanica
Mulchandani, Rubina
author_sort Misra, Sanjana
collection PubMed
description Cardiovascular Diseases (CVD) have a high disease burden in India. Dyslipidemia, a major CVD risk factor, requires effective management. Our review describes the appropriateness of the international dyslipidemia guidelines in the Indian context. A systematic search was performed in PubMed, Google Scholar, Cochrane Library and Science Direct to obtain relevant articles. Dyslipidemia management guidelines by western medical associations are based on their studies, with ethnic minorities underrepresented and biological features of other racial groups inadequately incorporated. The Lipid Association of India (LAI) came up with a consensus statement guided by an expert panel to adapt the western guidelines to Indians. However, absence of Indian guidelines has led to physicians basing treatment on individual preference, contributing to heterogeneity. Our review underscores the need for formulating Indian dyslipidemia management guidelines and CV risk estimation algorithms, highlighting the scope for further research. This could supplement the clinical expertise of LAI and enhance patient experience.
format Online
Article
Text
id pubmed-9647649
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-96476492022-11-15 Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research Misra, Sanjana Lyngdoh, Tanica Mulchandani, Rubina Indian Heart J Review Article Cardiovascular Diseases (CVD) have a high disease burden in India. Dyslipidemia, a major CVD risk factor, requires effective management. Our review describes the appropriateness of the international dyslipidemia guidelines in the Indian context. A systematic search was performed in PubMed, Google Scholar, Cochrane Library and Science Direct to obtain relevant articles. Dyslipidemia management guidelines by western medical associations are based on their studies, with ethnic minorities underrepresented and biological features of other racial groups inadequately incorporated. The Lipid Association of India (LAI) came up with a consensus statement guided by an expert panel to adapt the western guidelines to Indians. However, absence of Indian guidelines has led to physicians basing treatment on individual preference, contributing to heterogeneity. Our review underscores the need for formulating Indian dyslipidemia management guidelines and CV risk estimation algorithms, highlighting the scope for further research. This could supplement the clinical expertise of LAI and enhance patient experience. Elsevier 2022 2022-08-05 /pmc/articles/PMC9647649/ /pubmed/35940234 http://dx.doi.org/10.1016/j.ihj.2022.07.009 Text en © 2022 Cardiological Society of India. Published by Elsevier, a division of RELX India, Pvt. Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Misra, Sanjana
Lyngdoh, Tanica
Mulchandani, Rubina
Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
title Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
title_full Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
title_fullStr Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
title_full_unstemmed Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
title_short Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
title_sort guidelines for dyslipidemia management in india: a review of the current scenario and gaps in research
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647649/
https://www.ncbi.nlm.nih.gov/pubmed/35940234
http://dx.doi.org/10.1016/j.ihj.2022.07.009
work_keys_str_mv AT misrasanjana guidelinesfordyslipidemiamanagementinindiaareviewofthecurrentscenarioandgapsinresearch
AT lyngdohtanica guidelinesfordyslipidemiamanagementinindiaareviewofthecurrentscenarioandgapsinresearch
AT mulchandanirubina guidelinesfordyslipidemiamanagementinindiaareviewofthecurrentscenarioandgapsinresearch